Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response-Reference-Cited by-同舟云学术

Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response

Published:2017-05 Issue:5 Volume:16 Page:891-910
ISSN:1535-9476
Container-title:Molecular & Cellular Proteomics
language:en
Short-container-title:Molecular & Cellular Proteomics

Author:

Zhang Xu,Maity Tapan,Kashyap Manoj K.,Bansal Mukesh,Venugopalan Abhilash,Singh Sahib,Awasthi Shivangi,Marimuthu Arivusudar,Charles Jacob Harrys Kishore,Belkina Natalya,Pitts Stephanie,Cultraro Constance M.,Gao Shaojian,Kirkali Guldal,Biswas Romi,Chaerkady Raghothama,Califano Andrea,Pandey Akhilesh,Guha Udayan

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Analytical Chemistry

Reference74 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J. Clin,2013

2. Erlotinib hydrochloride;Dowell;Nat. Rev. Drug Discov,2005

3. Targeting protein kinases;Melnikova;Nat. Rev. Drug Discov,2004

4. Prolonged response to first-line erlotinib for advanced lung adenocarcinoma;Copeman;J. Exp. Clin. Cancer Res,2008

5. New predictors of survival for early-stage NSCLC;Sharma;Lancet Oncol,2007

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Rapid One-Pot Workflow for Sensitive Microscale Phosphoproteomics;Journal of Proteome Research;2024-07-22

2. Developing tyrosine phosphoproteome libraries and dual quantification using a hybrid DIA approach;Journal of the Chinese Chemical Society;2024-06-19

3. Elucidating the phosphoregulatory network of predominant phosphosite in AXL kinase: an integrative bioinformatic approach;Journal of Proteins and Proteomics;2024-06-19

4. Identification and Functional Characterization of Essential Genes Related to Gefitinib Sensitivity in Lung Adenocarcinoma;Current Medicinal Chemistry;2024-04-03

5. Acrizanib as a Novel Therapeutic Agent for Fundus Neovascularization via Inhibitory Phosphorylation of VEGFR2;Translational Vision Science & Technology;2024-01-02